Clinical Endpoint Bioequivalence Study of Test and Reference Inhalation Products in Patients With COPD With Device Robustness
Clinical trial NCT03137992 · COMPLETED
Trial details
- NCT number
- NCT03137992
- Sponsor
- Lupin, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-21
- Primary completion
- 2018-01-31
- Enrollment
- 377
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.